miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients
Top Cited Papers
- 15 October 2016
- journal article
- research article
- Published by Springer Science and Business Media LLC in Breast Cancer Research and Treatment
- Vol. 160 (3), 439-446
- https://doi.org/10.1007/s10549-016-4013-7
Abstract
Purpose The proper validation of prognostic biomarkers is an important clinical issue in breast cancer research. MicroRNAs (miRNAs) have emerged as a new class of promising breast cancer biomarkers. In the present work, we developed an integrated online bioinformatic tool to validate the prognostic relevance of miRNAs in breast cancer. Methods A database was set up by searching the GEO, EGA, TCGA, and PubMed repositories to identify datasets with published miRNA expression and clinical data. Kaplan–Meier survival analysis was performed to validate the prognostic value of a set of 41 previously published survival-associated miRNAs. Results All together 2178 samples from four independent datasets were integrated into the system including the expression of 1052 distinct human miRNAs. In addition, the web-tool allows for the selection of patients, which can be filtered by receptors status, lymph node involvement, histological grade, and treatments. The complete analysis tool can be accessed online at: www.kmplot.com/mirpower. We used this tool to analyze a large number of deregulated miRNAs associated with breast cancer features and outcome, and confirmed the prognostic value of 26 miRNAs. A significant correlation in three out of four datasets was validated only for miR-29c and miR-101. Conclusions In summary, we established an integrated platform capable to mine all available miRNA data to perform a survival analysis for the identification and validation of prognostic miRNA markers in breast cancer.Keywords
Funding Information
- Hungarian Scientific Research Fund (K 108655)
- Associazione Italiana per la Ricerca sul Cancro (6251)
- Fondazione Italiana per la Ricerca sul Cancro (18328)
This publication has 31 references indexed in Scilit:
- Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient managementBreast Cancer Research, 2015
- MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast CancerTheranostics, 2015
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012International Journal of Cancer, 2014
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013Annals Of Oncology, 2013
- Prognostic microRNA/mRNA signature from the integrated analysis of patients with invasive breast cancerProceedings of the National Academy of Sciences of the United States of America, 2013
- MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive reviewEMBO Molecular Medicine, 2012
- microRNA-Associated Progression Pathways and Potential Therapeutic Targets Identified by Integrated mRNA and microRNA Expression Profiling in Breast CancerCancer Research, 2011
- Emerging Biomarkers and New Understanding of Traditional Markers in Personalized Therapy for Breast CancerClinical Cancer Research, 2008
- MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtypeGenome Biology, 2007
- MicroRNA Gene Expression Deregulation in Human Breast CancerCancer Research, 2005